Healthcare -
Biotechnology - NASDAQ - US
$ 30.91
-1.4 %
$ 2.01 B
Market Cap
-10.37
P/E
KYMR - DEPRECIATION & AMORTIZATION
Depreciation & Amortization KYMR - Kymera Therapeutics, Inc.
3.56 M
LAST VALUE
21.95%
2 YEAR CAGR
77.04%
5 YEAR CAGR
0.00%
10 YEAR CAGR